GPCR/G protein - Na /Ca2 Exchangers (NCXs) - 5-HT1 Receptor - LPA Receptors - NPY Receptors
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B7155 BIBP 3226 trifluoroacetateTarget: NPY Receptors|NPFF receptorSummary: 混合NPY Y1和NPFF受体拮抗剂
- B6347 Methylergometrine maleate中文名: 马来酸甲麦角新碱Target: 5-HT1 Receptor|5-HT2 ReceptorSummary: 5-HT1/5-HT2受体拮抗剂
- B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: 激活LPA受体
- B1591 Ki16198Target: LPA ReceptorsSummary: LPA拮抗剂
- B2251 Naratriptan中文名: 盐酸那拉曲坦,盐酸纳拉曲坦Target: 5-HT1 ReceptorSummary: 选择性5-HT1受体亚型激动剂
- A1987 Ki164254 CitationTarget: LPA ReceptorsSummary: LPA受体拮抗剂
- A3811 SEA04004 CitationTarget: Na /Ca2 Exchangers (NCXs)Summary: 特异性的Na+/Ca2+交换抑制剂
- A3170 AM9662 CitationTarget: LPA ReceptorsSummary: LPA1拮抗剂
- A3167 AM-095 free baseTarget: LPA ReceptorsSummary: 有效的LPA1受体拮抗剂